# 🚀 GNN Drug-Gene Interaction Project - Execution Checklist

## Master Timeline: 4-5 Weeks | 35 Days Total

---

## ✅ PHASE 1: ENVIRONMENT & DATA SETUP (Days 1-4)

### Infrastructure Setup (Days 1-2)
- [ ] Create GitHub repository with professional README
- [ ] Set up project structure with all directories
- [ ] Create Python virtual environment (`python -m venv gnn_env`)
- [ ] Install core dependencies:
  ```bash
  pip install torch pytorch-geometric rdkit scikit-learn pandas numpy
  pip install matplotlib seaborn plotly tensorboard jupyter
  ```
- [ ] Test installations with simple import script
- [ ] Set up `.gitignore` (exclude data/, results/, *.pt files)
- [ ] Create `requirements.txt` with pinned versions

### Data Acquisition (Days 2-4)
- [ ] Download GDSC database from https://www.cancerrxgene.org
  - [ ] IC50 values for 655 cell lines × 119 drugs
  - [ ] Drug SMILES strings
  - [ ] Gene names/IDs for mapping
- [ ] Download CCLE gene expression data from https://sites.broadinstitute.org/ccle
  - [ ] RNA-seq (RSEM) for 1,019 cell lines
  - [ ] Filter to matching cell lines (overlap ~600)
- [ ] Store raw data in `data/raw/` directory
- [ ] Create data manifest file (CSV with file descriptions)
- [ ] Verify data integrity:
  - [ ] No missing critical columns
  - [ ] SMILES strings are valid
  - [ ] Gene names standardized (HGNC symbols)
  - [ ] IC50 values in reasonable range (0.001 - 100 µM)

**Deliverable**: 
- Working virtual environment
- Downloaded GDSC & CCLE files verified
- Data manifest document

---

## ✅ PHASE 2: DATA PROCESSING PIPELINE (Days 5-10)

### SMILES → Molecular Graphs Conversion (Days 5-6)
- [ ] Implement `SMILEStoGraphConverter` class (✓ provided)
- [ ] Create atom feature extraction (atomic number, degree, aromaticity, etc.)
- [ ] Create bond feature extraction (bond type, aromaticity, conjugation)
- [ ] Test on example SMILES:
  ```python
  converter = SMILEStoGraphConverter()
  graph = converter.smiles_to_graph("CC(=O)Oc1ccccc1C(=O)O")
  assert graph.x.shape[0] > 0  # Has atoms
  assert graph.edge_index.shape[1] > 0  # Has bonds
  ```
- [ ] Batch convert all GDSC drugs to graphs
- [ ] Save graphs as pickle for reuse
- [ ] Verify feature dimensions:
  - [ ] Atom features: 44D ✓
  - [ ] Bond features: 3D ✓
  - [ ] Variable molecule sizes handled

### Gene Expression Preprocessing (Days 6-7)
- [ ] Load CCLE expression data
- [ ] Standardize gene naming (ensure HGNC symbols)
- [ ] Handle missing values:
  - [ ] Impute with 0 (unexpressed)
  - [ ] Or use KNN imputation
- [ ] Normalize expression values:
  - [ ] Log2(expression + 1) transformation
  - [ ] Z-score normalization per gene
- [ ] Feature selection:
  - [ ] Select ~12,000 most variable genes (keep all CCLE genes)
  - [ ] Document gene filtering criteria
- [ ] Verify normalized data:
  - [ ] Mean ≈ 0, Std ≈ 1 per gene
  - [ ] No NaN values

### Dataset Assembly (Days 7-10)
- [ ] Create drug-cell-IC50 triplets:
  - [ ] Match drugs in GDSC to molecular graphs
  - [ ] Match cell lines in CCLE to GDSC
  - [ ] Keep only valid triplets (~78,000 data points)
- [ ] Implement PyTorch Dataset class:
  ```python
  class DrugResponseDataset(Dataset):
      def __getitem__(self, idx):
          return (drug_graph, gene_expr_vector, ic50_label)
  ```
- [ ] Create train/validation/test splits:
  - [ ] 60% train (40K samples)
  - [ ] 20% validation (15K samples)
  - [ ] 20% test (15K samples)
  - [ ] Stratify by tissue type (avoid leakage)
- [ ] Save processed data as PyTorch files
- [ ] Create data statistics notebook:
  - [ ] Sample count distributions
  - [ ] IC50 distribution (log scale)
  - [ ] Gene expression ranges
  - [ ] Molecule size statistics

**Deliverable**:
- `data/processed/` directory with train/val/test splits
- All drugs converted to graphs (pickled)
- All cell lines with normalized expression (numpy arrays)
- `01_data_exploration.ipynb` with visualizations
- Data statistics document

---

## ✅ PHASE 3: MODEL ARCHITECTURE (Days 11-18)

### Drug Encoder - Graph Attention Network (Days 11-13)
- [ ] Implement `DrugEncoder` class (✓ provided)
- [ ] Configure GAT layers:
  - [ ] Layer 1: 44D → 128D (8 heads)
  - [ ] Layer 2: 1024D → 128D (8 heads)
  - [ ] Layer 3: 1024D → 128D (1 head)
- [ ] Add batch normalization between layers
- [ ] Add dropout (0.1) for regularization
- [ ] Test with single molecule:
  ```python
  encoder = DrugEncoder()
  drug_embed = encoder(x, edge_index, batch=None)
  assert drug_embed.shape == (1, 128)
  ```
- [ ] Profile memory/speed on batch of 32 molecules
- [ ] Document attention head visualization capability

### Cell Line Encoder - Dense Network (Days 13-14)
- [ ] Implement `CellLineEncoder` class (✓ provided)
- [ ] Configure dense layers:
  - [ ] 12,072 → 1,024 (BatchNorm + ReLU)
  - [ ] 1,024 → 512 (BatchNorm + ReLU)
  - [ ] 512 → 256 (BatchNorm + ReLU)
  - [ ] 256 → 128 (output)
- [ ] Add dropout (0.2) for regularization
- [ ] Test with batch of 32 expression vectors:
  ```python
  encoder = CellLineEncoder()
  cell_embed = encoder(gene_expr)
  assert cell_embed.shape == (32, 128)
  ```

### Integration Module - Attention Fusion (Days 14-15)
- [ ] Implement `MultiHeadAttentionFusion` class (✓ provided)
- [ ] Configure multi-head attention:
  - [ ] 4 attention heads
  - [ ] 128D embeddings
  - [ ] Bidirectional cross-attention
- [ ] Test fusion:
  ```python
  fusion = MultiHeadAttentionFusion()
  drug_embed = torch.randn(32, 128)
  cell_embed = torch.randn(32, 128)
  fused = fusion(drug_embed, cell_embed)
  assert fused.shape == (32, 128)
  ```

### Prediction Head (Days 15-16)
- [ ] Implement prediction layers:
  - [ ] 128 → 256 (BatchNorm + ReLU)
  - [ ] 256 → 128 (BatchNorm + ReLU)
  - [ ] 128 → 1 (output: IC50)
- [ ] MSE loss for regression

### Full Model Integration (Days 16-18)
- [ ] Integrate all components into `DrugResponsePredictor`
- [ ] Forward pass test:
  ```python
  model = DrugResponsePredictor()
  drug_batch = Batch.from_data_list([graphs])
  gene_expr = torch.randn(1, 12072)
  ic50_pred = model(drug_batch, gene_expr)
  assert ic50_pred.shape == (1, 1)
  ```
- [ ] Count total parameters (should be ~4-5M)
- [ ] Parameter breakdown analysis:
  - [ ] Drug encoder: ~2M
  - [ ] Cell encoder: ~1.5M
  - [ ] Fusion: ~0.2M
  - [ ] Predictor: ~0.3M
- [ ] Move to GPU and test memory usage
- [ ] Create model architecture diagram
- [ ] Save model summary to file

**Deliverable**:
- Complete `DrugResponsePredictor` implementation
- Model architecture visualization
- Unit tests for each component
- `02_model_development.ipynb` with architecture explanations
- Model parameter analysis

---

## ✅ PHASE 4: TRAINING & OPTIMIZATION (Days 19-28)

### Training Loop Setup (Days 19-20)
- [ ] Implement `DrugResponseTrainer` class (✓ provided)
- [ ] Configure optimizer: Adam with lr=0.001
- [ ] Configure learning rate scheduler: StepLR (decay=0.5 every 50 epochs)
- [ ] Loss function: MSELoss
- [ ] Early stopping: patience=20 epochs
- [ ] Batch loading: handle mixed drug graphs + gene vectors
- [ ] GPU memory optimization:
  - [ ] Gradient accumulation if needed
  - [ ] Mixed precision training (optional)
- [ ] Create training configuration file (`config/config.yaml`)

### Hyperparameter Search (Days 20-22)
- [ ] Grid search over:
  - [ ] Learning rates: [0.0001, 0.0005, 0.001, 0.005]
  - [ ] Batch sizes: [16, 32, 64]
  - [ ] Dropout rates: [0.1, 0.2, 0.3]
  - [ ] Embedding dimensions: [64, 128, 256]
- [ ] Track all experiments in log file
- [ ] Select best hyperparameters based on validation R²
- [ ] Document hyperparameter justification

### Training Execution (Days 22-25)
- [ ] Train with best hyperparameters for 200 epochs
- [ ] Monitor metrics:
  - [ ] Train loss per epoch
  - [ ] Validation loss per epoch
  - [ ] RMSE, MAE, Pearson CC, R² (validation)
- [ ] Create TensorBoard logs for visualization
- [ ] Save checkpoints:
  - [ ] Best model (lowest val loss)
  - [ ] Every 10 epochs (optional)
  - [ ] Latest checkpoint
- [ ] Expected training time: 8-12 hours (GPU)
- [ ] Expected metrics:
  - [ ] RMSE: < 0.85
  - [ ] Pearson CC: > 0.88
  - [ ] R²: > 0.76

### Validation & Testing (Days 25-28)
- [ ] Evaluate on validation set during training
- [ ] Evaluate on held-out test set after training
- [ ] Calculate comprehensive metrics:
  - [ ] RMSE, MAE, MAPE
  - [ ] Pearson correlation, Spearman correlation
  - [ ] R² score, Adjusted R²
  - [ ] Percentage within X% of actual IC50
- [ ] Create prediction vs actual plots
- [ ] Perform error analysis:
  - [ ] Errors by drug class
  - [ ] Errors by tissue type
  - [ ] Errors by IC50 range
- [ ] Create `03_training_evaluation.ipynb`:
  - [ ] Training curves
  - [ ] Metric progression
  - [ ] Test set evaluation
  - [ ] Error distributions

**Expected Results**:
- RMSE: 0.78 ± 0.05
- Pearson CC: 0.91 ± 0.03
- R²: 0.83 ± 0.04

**Deliverable**:
- Trained model checkpoint (`best_model.pt`)
- Training logs and metrics
- Test set predictions CSV
- Performance analysis notebook
- Comparison to baseline methods

---

## ✅ PHASE 5: EXPLAINABILITY & INTERPRETATION (Days 29-33)

### GNNExplainer Implementation (Days 29-30)
- [ ] Implement `GNNExplainer` class:
  ```python
  explainer = GNNExplainer(model)
  node_mask, edge_mask = explainer.explain_prediction(drug_graph, gene_expr)
  ```
- [ ] Identify important molecular substructures:
  - [ ] Highlight atoms contributing most to prediction
  - [ ] Highlight bonds contributing most to prediction
- [ ] Verify explanations are chemically sensible
- [ ] Test on known drug mechanisms:
  - [ ] Tyrosine kinase inhibitors (should identify ATP pocket)
  - [ ] DNA intercalators (should identify aromatic cores)
  - [ ] Hormonally-active drugs (should identify receptor domains)

### Gene Importance Analysis (Days 30-31)
- [ ] Use integrated gradients to rank genes by importance
- [ ] For each prediction, identify top 10-20 important genes
- [ ] Validate against known cancer drivers:
  - [ ] TP53 for many cell lines
  - [ ] EGFR for lung cancer
  - [ ] KRAS for pancreatic cancer
- [ ] Create heatmap: genes vs top drug-cell pairs

### Biological Interpretation (Days 31-32)
- [ ] Map important genes to biological pathways:
  - [ ] Use STRING database or KEGG
  - [ ] Identify enriched pathways
- [ ] Identify active drug substructures:
  - [ ] Compare to known pharmacophores
  - [ ] Check against medicinal chemistry literature
- [ ] Create case studies:
  - [ ] Select 3-5 representative drug-cell pairs
  - [ ] Show molecule with important atoms highlighted
  - [ ] Show associated genes and pathways
  - [ ] Explain why model predicts high/low sensitivity

### Visualization & Documentation (Days 32-33)
- [ ] Create publication-quality figures:
  - [ ] Highlighted molecular structures (RDKit)
  - [ ] Gene importance heatmaps
  - [ ] Pathway diagrams
  - [ ] UMAP/t-SNE of learned embeddings
- [ ] Create `04_biological_interpretation.ipynb`:
  - [ ] Explainability methodology
  - [ ] Case study visualizations
  - [ ] Biological validation
  - [ ] Mechanistic insights
- [ ] Write biological interpretation report

**Deliverable**:
- GNNExplainer implementation
- Highlighted molecular structures (10+ drugs)
- Gene importance rankings
- Pathway enrichment analysis
- Biological interpretation notebook
- Case study documentation

---

## ✅ PHASE 6: PORTFOLIO & DEPLOYMENT (Days 34-35)

### Code Repository Finalization (Day 34)
- [ ] Clean up code, remove debug prints
- [ ] Add docstrings to all functions
- [ ] Create unit tests:
  ```python
  python -m pytest tests/
  ```
- [ ] Run linting: `flake8 src/`
- [ ] Format code: `black src/`
- [ ] Add type hints throughout
- [ ] Update `.gitignore`:
  - [ ] Exclude large data files (*.pt, *.pkl)
  - [ ] Exclude results/ directory
- [ ] Create CONTRIBUTING.md
- [ ] Add LICENSE (MIT)

### Documentation (Day 34)
- [ ] Update main README.md with all details:
  - [ ] ✓ Project overview
  - [ ] ✓ Installation instructions
  - [ ] ✓ Quick start guide
  - [ ] ✓ Architecture explanation
  - [ ] ✓ Results & benchmarks
  - [ ] ✓ Usage examples
  - [ ] ✓ Explainability section
  - [ ] ✓ Dataset description
  - [ ] ✓ Citation info
- [ ] Create INSTALLATION.md with detailed steps
- [ ] Create USAGE.md with code examples
- [ ] Document data formats in DATA.md
- [ ] Create API documentation

### LinkedIn & Networking (Day 35)
- [ ] Write LinkedIn post (3-5 parts):
  - [ ] Part 1: Problem motivation (precision oncology)
  - [ ] Part 2: Technical approach (architecture)
  - [ ] Part 3: Results & performance
  - [ ] Part 4: Biological insights
  - [ ] Part 5: GitHub & open-source
- [ ] Include:
  - [ ] Project summary image
  - [ ] Architecture diagram
  - [ ] Performance metrics table
  - [ ] Key insights
  - [ ] GitHub link
  - [ ] Call to action
- [ ] Tag relevant people/companies:
  - [ ] IBM Research (@IBM)
  - [ ] AbbVie Research
  - [ ] Graph neural network communities
- [ ] Share on Twitter/X
- [ ] Update GitHub with LinkedIn badge

### Technical Blog Post (Optional, Day 35)
- [ ] Write Medium article: "Building a Drug Discovery AI with GNNs"
  - [ ] Background on pharmacogenomics
  - [ ] Why GNNs matter for molecules
  - [ ] Architecture walkthrough
  - [ ] Key insights from GNNExplainer
  - [ ] Future directions
- [ ] Include code snippets and visualizations

### Final Deliverables Checklist
- [ ] GitHub repository:
  - [ ] Clean, organized code
  - [ ] Professional README
  - [ ] All notebooks uploaded
  - [ ] Training/evaluation scripts
  - [ ] Configuration files
  - [ ] Unit tests
- [ ] Results folder:
  - [ ] Best trained model
  - [ ] Training logs
  - [ ] Performance metrics
  - [ ] Test set predictions
  - [ ] Visualizations
- [ ] Documentation:
  - [ ] README.md ✓
  - [ ] INSTALLATION.md
  - [ ] USAGE.md
  - [ ] DATA.md
  - [ ] API docs
- [ ] Portfolio items:
  - [ ] LinkedIn post (3-5 parts)
  - [ ] Blog post (optional)
  - [ ] GitHub link
  - [ ] Project summary PDF

---

## 📅 TIMELINE SUMMARY

| Week | Days | Phase | Deliverable |
|------|------|-------|------------|
| 1 | 1-4 | Setup & Data | GDSC/CCLE data downloaded, environment ready |
| 2 | 5-10 | Processing | Train/val/test splits, graphs created |
| 2-3 | 11-18 | Architecture | Full model implemented, tested |
| 3-4 | 19-28 | Training | Trained model, performance metrics |
| 4 | 29-33 | Explainability | GNNExplainer, biological insights |
| 5 | 34-35 | Portfolio | GitHub, LinkedIn, blog post |

---

## 🎯 SUCCESS CRITERIA

### Technical Metrics
- [ ] RMSE < 0.85 on test set
- [ ] Pearson correlation > 0.88
- [ ] R² > 0.76
- [ ] Model trains in < 12 hours
- [ ] Inference speed > 40 samples/second

### Code Quality
- [ ] 100% docstring coverage
- [ ] All tests passing
- [ ] No lint warnings
- [ ] Type hints on all functions
- [ ] Clear, readable code structure

### Portfolio Presentation
- [ ] Professional GitHub repository
- [ ] Comprehensive README
- [ ] Working training/evaluation scripts
- [ ] Published LinkedIn post
- [ ] Multiple notebook tutorials

### Biological Validity
- [ ] Important genes align with literature
- [ ] Active drug substructures are chemically sensible
- [ ] Pathway enrichment shows meaningful results
- [ ] Case studies demonstrate mechanism understanding

---

## 🚨 RISK MITIGATION

| Risk | Likelihood | Mitigation |
|------|-----------|-----------|
| SMILES parsing fails | Low | Use RDKit validation, handle gracefully |
| Data merge has gaps | Low | Create merge report, verify counts |
| Training diverges | Low | Gradient clipping, learning rate scheduling |
| GPU out of memory | Medium | Use gradient accumulation, reduce batch size |
| Overfitting | Medium | Early stopping, dropout, regularization |
| Missing imports | Low | Test imports on clean environment |
| GitHub sync issues | Low | Regular commits, clear git workflow |

---

## 📞 SUPPORT RESOURCES

- **PyTorch Geometric Docs**: https://pytorch-geometric.readthedocs.io/
- **RDKit Documentation**: https://www.rdkit.org/docs/
- **GDSC Database**: https://www.cancerrxgene.org/
- **CCLE Database**: https://sites.broadinstitute.org/ccle/
- **GNNExplainer Paper**: Ying et al. (2019)
- **Graph Attention Networks**: Veličković et al. (2018)

---

## ✍️ Notes & Updates

**Last Updated**: January 16, 2026
**Status**: Ready for execution
**Estimated Total Time**: 35 days (can be parallelized to ~25 days with effort)

---

**Ready to build something groundbreaking?** 🚀

This timeline is aggressive but achievable with focused work. The parallelization opportunities are:
- Data processing while architecture is being coded
- Training while writing documentation
- Multiple model variations tested simultaneously (GPU cluster)

**Good luck!** 🧬
